日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade.

一种具有跨菌株抗AMA1人类单克隆抗体可以中和疟原虫,而无需直接阻断RON2L受体

Patel Palak N, Diouf Ababacar, Dickey Thayne H, Tang Wai Kwan, Hopp Christine S, Traore Boubacar, Long Carole A, Miura Kazutoyo, Crompton Peter D, Tolia Niraj H

A combined designed CSP and Pfs48/45 infection and transmission blocking vaccine for malaria.

一种结合了CSP和Pfs48/45的疟疾感染和传播阻断技术的疫苗

Gupta Richi, Dickey Thayne H, Salinas Nichole D, Patel Palak N, Ma Rui, Shi Dashuang, Singleton Myesha, Ouahes Tarik, Pham Thao P, Miura Kazutoyo, Long Carole A, Lambert Lynn E, Tolia Niraj H

RH5 antigenic landscape shapes vaccine and antibody development

RH5抗原谱影响疫苗和抗体的研发

Patel, Palak N; Tolia, Niraj H

Structural vaccinology of malaria transmission-blocking vaccines

疟疾传播阻断疫苗的结构疫苗学

Patel, Palak N; Tolia, Niraj